Remap Consulting are ideally placed to support the completion of price certificates ready for legali...
Read moreGVD is a core document, which may be considered the “heart” of the pharmaceutical product’s pa...
Read moreHow has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...
Read moreWithout a doubt, the impact of COVID-19 will influence all sectors, including the future of market a...
Read moreIRP is a pricing mechanism where the price of a drug in one country is set or adjusted in relation t...
Read moreWe received fabulous feedback, with responses from at least 15 industry executives across global pha...
Read moreDifferences in market access and reimbursement processes are an important factor in determining the ...
Read moreThis resolution includes proposed reforms to the market access (including pricing) landscape designe...
Read more"Market Access" describes activities and processes that pharmaceutical and biotech companies underta...
Read morePrescription drug prices in the US rank among the highest in the world and the US spent $1220 on ph...
Read more